baseline characteristics of the trial participants, according to study group* - part i

9
Baseline Characteristics of the Trial Participants, According to Study Group* - Part I PM Ridker, et al. N Engl J Med 2008;359:2195-207

Upload: addison-camacho

Post on 02-Jan-2016

24 views

Category:

Documents


1 download

DESCRIPTION

Baseline Characteristics of the Trial Participants, According to Study Group* - Part I. PM Ridker, et al. N Engl J Med 2008;359:2195-207. Baseline Characteristics of the Trial Participants, According to Study Group* - Part II. PM Ridker, et al. N Engl J Med 2008;359:2195-207. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 2: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Baseline Characteristics of the Trial Participants, According to Study Group* - Part II

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 3: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Lipid and High-Sensitivity C-Reactive Protein Levels during the Follow-up Period, According to Study Group*

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 4: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Outcomes According to Study Group

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 5: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Cumulative Incidence of Cardiovascular Events According to Study Group

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 6: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Effects of Rosuvastatin on the Primary End Point, According to Baseline Characteristics

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 7: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Monitored Adverse Events, Measured Laboratory Values, and Other Reported Events of Interest during the Follow-up Period*

PM Ridker, et al. N Engl J Med 2008;359:2195-207

Page 8: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Trial schematic

PM Ridker, et al. N Engl J Med 2008;359:2195-207 - Online Supplemental Appendix

Page 9: Baseline Characteristics of the Trial Participants, According to Study Group* - Part I

Relationship of the proportional reduction in cardiovascular event rate and mean LDL cholesterol difference between

treatment groups in published statin trials

PM Ridker, et al. N Engl J Med 2008;359:2195-207 - Online Supplemental Appendix